glutathione pathway to triple negative cancer Activation of the eIF2α/ATF4 axis drives triple-negative breast radioresistance by promoting biosynthesis Glutathione Metabolism in Renal Cell
Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies CD36 enhances sensitivity of triple negative breast cancer cells to palmitate induced ferroptosis Cell Death & Disease Targeting Glutathione Metabolism: Partner in Crime in Anticancer Therapy Glutathione metabolism in cancer progression and treatment resistance PMC Metabolic reprogramming in triple negative breast cancer PMC Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression ScienceDirect
Pay in 4 interest-free payments of $7.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14





